Antiemetics in patients receiving chemotherapy for cancer: a randomized
comparison of delta-9-tetrahydrocannabinol and prochlorperazine

Structure‐dependent inhibitory effects of synthetic cannabinoids against
12‐O ‐tetradecanoylphorbol‐13‐acetate‐induced
inflammation and skin tumor promotion in mice

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt

Cannabis and Cannabinoids (PDQ®)–Health Professional Version (National Cancer Institute)

Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy

Medical Cannabis –

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration

Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer

Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer

CBD Reverts the Mesenchymal Invasive Phenotype of Breast Cancer Cells Induced by the Inflammatory Cytokine IL-1β

Δ9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation